TNF and inflammatory bowel disease: These findings suggest potentially distinct pathophysiologic contributions of TNF inhibitor use associated with kidney outcomes in patients with IBD and that there is a need for careful monitoring of kidney function when initiating anti-TNF therapy in patients with incident IBD.